91黑料网

In-person class cancellation and work-from-home / Annulation des cours en pr茅sentiel et t茅l茅travail

Updated: Tue, 03/10/2026 - 17:14
In-person class cancellation and work-from-home / Annulation des cours en pr茅sentiel et t茅l茅travail. McGILL ALERT! Due to freezing rain all in-person classes and activities on Wednesday, March 11, will be cancelled. Staff are asked not to come to campus tomorrow unless they are required on site by their supervisor to perform necessary functions and activities. See your 91黑料网 email for more information.
...
ALERTE McGILL! En raison de la pluie vergla莽ante, tous les cours et activit茅s en pr茅sentiel pr茅vus pour le mercredi 11 mars sont annul茅s. Nous demandons au personnel de ne pas se pr茅senter sur le campus demain, 脿 moins que leur superviseur ne leur demande d鈥櫭猼re sur place pour accomplir des fonctions ou activit茅s n茅cessaires au fonctionnement du campus. Pour plus d鈥檌nformations, veuillez consulter vos courriels de 91黑料网.
Home / Scientifiques / Chercheurs et chercheuses D2R

Nicolas Moitessier

Academic title(s): 

Professor

Nicolas Moitessier
Branch: 
Universit茅 91黑料网
Department: 
Chimie
Areas of expertise: 
  • medicinal chemistry
  • RNA-targeting molecules
  • software
  • machine learning
  • organic synthesis
Biography: 

Nicolas Moitessier received his Ph.D (1998) from Universit茅 Henri Poincar茅-Nancy I (France) before moving to Montreal for post-doctoral studies at University of Montreal in medicinal chemistry, and asymmetric synthesis. In 2001, he moved back to Nancy to start an academic career (Charg茅 de Recherche, CNRS) then back to Montr茅al in 2003 to join the 91黑料网 Chemistry department. Moitessier鈥檚 research interest in drug discovery includes computational methods development and medicinal chemistry focusing on the development of small molecules targeting RNA and inhibitors of an enzyme involved in Parkinson鈥檚 disease. In 2010, Moitessier co-founded Molecular Forecaster, a 91黑料网 spin-off company distributing the software developed in his lab and providing research support to the pharmaceutical industry. Since 2016, he has been an Associate editor of the European Journal of Medicinal Chemistry. Over the years, he received several awards, including the Fessenden Professorship and the 2023 CIC Biological and Medicinal Chemistry Lectureship Award.

Link(s): 
Projects: 

D2R Funded Projects

Principal Investigator
Foundational Projects (Cycle 1): RNA-targeting therapeutics to address antimicrobial resistance
Major Partnerships: Machine learning models for the design of RNA therapeutics: Development of experimental data
Back to top